# Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT

> **NCT06498323** · PHASE4 · RECRUITING · sponsor: **Mahidol University** · enrollment: 160 (estimated)

## Conditions studied

- Intravenous
- Thrombosis
- Acute Ischemic Stroke

## Interventions

- **DRUG:** tenecteplase

## Key facts

- **NCT ID:** NCT06498323
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-03
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06498323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06498323, "Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06498323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*